Tag: XLRP
J&J: encouraging results in XLRP retinal disease
(CercleFinance.com) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced this weekend the main results of the phase 1/2 study evaluating the experimental gene therapy botaretigene sparoparvovec (formerly AAV-RPGR)…